The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
Open accessAbstract
Background Comprehensive long-term data on atrial fibrillation trends in men and women are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 years.Methods We investigated trends in incidence, prevalence, and risk factors for atrial fibrillation and its association with stroke and mortality after onset in 9511 participants enrolled in the Framingham Heart Study between 1958 and 2007. We analysed trends within 10 year groups (1958-67, 1968-77, 1978-87, 1988-97, and 1998-2007), stratified by sex.Findings During 50 years of observation (202,417 person-years), 1544 cases of new-onset atrial fibrillation occurred (of whom 723 [47%] were women). Between 1958-67 and 1998-2007, age-adjusted prevalence of atrial fibrillation quadrupled from 20·4 to 96·2 cases per 1000 person-years in men and from 13·7 to 49·4 cases per 1000 person-years in women; age-adjusted incidence increased from 3·7 to 13·4 new cases per 1000 person-years in men and from 2·5 to 8·6 new cases per 1000 person-years in women (ptrend<0·0001 for all comparisons). For atrial fibrillation diagnosed by electrocardiograph (ECG) during routine Framingham examinations, age-adjusted prevalence per 1000 person-years increased (12·6 in 1958-67 to 25·7 in 1998-2007 in men, ptrend=0·0007; 8·1 to 11·8 in women, ptrend=0·009). However, age-adjusted incidence of atrial fibrillation by Framingham Heart Study ECGs did not change significantly with time. Although the prevalence of most risk factors changed over time, their associated hazards for atrial fibrillation changed little. Multivariable-adjusted proportional hazards models revealed a 74% (95% CI 50-86%) decrease in stroke (hazards ratio [HR] 3·77, 95% CI 1·98-7·20 in 1958-1967 compared with 1998-2007; ptrend=0·0001) and a 25% (95% CI -3-46%) decrease in mortality (HR 1·34, 95% CI 0·97-1·86 in 1958-1967 compared with 1998-2007; ptrend=0·003) in 20 years following atrial fibrillation onset.Interpretation Trends of increased incidence and prevalence of atrial fibrillation in the community were probably partly due to enhanced surveillance. Measures are needed to enhance early detection of atrial fibrillation, through increased awareness coupled with targeted screening programmes and risk factor-specific prevention.Funding NIH, NHLBI, NINDS, Deutsche Forschungsgemeinschaft.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly to incidence, age-adjusted prevalence of AF has been reported to be lower in women than in men in North America and Europe (Figure 2) (Supplementary Tables S3 and S4).”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Hypertension (treated) vs. none 19 HR 1.32 (95% CI 1.08-1.60)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Heart failure vs. none 19 HR 1.43 (95% CI 0.85-2.40)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Older age 19 50-59 years 60-69 years 70-79 years 80-89 years HR: 1.00 (reference) 4.98 (95% CI 3.49-7.10) 7.35 (95% CI 5.28-10.2) 9.33 (95% CI 6.68-13.0)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Obesity 19, 208 none (BMI < 25 kg/m²) overweight (BMI 25-30 kg/m²) obese (BMI ≥ 31 kg/m²) HR: 1.00 (reference) 1.13 (95% CI 0.87-1.46)1.37 (95% CI 1.05-1.78)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Myocardial infarction vs. none 19 HR 1.46 (95% CI 1.07-1.98)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Diabetes mellitus vs. none 19 HR 1.25 (95% CI 0.98-1.60)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“In North American and European populations, the age-adjusted incidence of AF has been estimated to be 1.5 to 2 times higher in men than in women (Supplementary Tables S1 and S2).”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“Elevated body mass index, hypertension, diabetes mellitus, coronary heart disease, valvular heart disease, and heart failure (HF) constitute major risk factors for AF, but the prevalence of these risk factors vary between women and men.3–5”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“Women with AF have higher prevalence of hypertension and valvular heart disease and lower prevalence of coronary heart disease than men with AF.5,11,34”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“However, in studies from North America,5 Europe,34,35 and Australia,11 women with AF are, on average, older than men.”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“In particular, body mass index has increased significantly (Figure 3).5”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Analysis of Count Data
Cameron, A. C., & Trivedi, P. K. (2013) · doi:10.1017/cbo9781139013567 · Cited by 6,640
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Self-citationExplaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citation
Cited by
Sorted by citations
Items 101–200 of 1,000
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Wilkinson, C., Mamas, M. A., Camm, A. J., & Gale, C. P. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100386 · Cited by 110
Williams, B. A., Chamberlain, A. M., Blankenship, J. C., Hylek, E. M., & Voyce, S. J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.14874 · Cited by 108
Shin, S., Burnett, R. T., Kwong, J. C., Hystad, P., van Donkelaar, A., Brook, J. R., Goldberg, M. S., Tu, K., Copes, R., Martin, R. V., et al. (2019) · Environmental Health Perspectives · doi:10.1289/ehp4883 · Cited by 111
García, M., Ródenas, J., Alcaraz, R., & Rieta, J. J. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.04.009 · Cited by 107
Christophersen, I. E., Yin, X., Larson, M. G., Lubitz, S. A., Magnani, J. W., McManus, D. D., Ellinor, P. T., & Benjamin, E. J. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.05.004 · Cited by 102
Li, Y., Bisson, A., Bodin, A., Herbert, J., Grammatico‐Guillon, L., Joung, B., Wang, Y., Lip, G. Y. H., & Fauchier, L. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012546 · Cited by 102
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676037 · Cited by 104
Volgman, A. S., Benjamin, E. J., Curtis, A. B., Fang, M. C., Lindley, K. J., Naccarelli, G. V., Pepine, C. J., Quesada, O., Vaseghi, M., Waldo, A. L., et al. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14838 · Cited by 114
Romiti, G. F., Guo, Y., Corica, B., Proietti, M., Zhang, H., Lip, G. Y. H., & on behalf of the mAF-App II trial investigators (2023) · Thrombosis and Haemostasis · doi:10.1055/s-0043-1769612 · Cited by 103
Zhu, W., Yuan, P., Shen, Y., Wan, R., & Hong, K. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.05.013 · Cited by 102
Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation
Alkhouli, M. A., & Friedman, P. A. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.040 · Cited by 104
Yun, S., Vincelette, N. D., Acharya, U. H., & Abraham, I. L. (2016) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2016.09.010 · Cited by 100
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 106
Accelerometer-derived physical activity and risk of atrial fibrillation
Khurshid, S. S., Weng, L.-C. C., Al‐Alusi, M. A., Halford, J. L., Haimovich, J. S., Benjamin, E. J., Trinquart, L., Ellinor, P. T., McManus, D. D., & Lubitz, S. A. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab250 · Cited by 98
Nielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Sex Differences in Atrial Fibrillation
Andrade, J. G., Deyell, M. W., Lee, A. K. Y., & Macle, L. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.11.022 · Cited by 100
Himmelreich, J. C. L., Veelers, L., Lucassen, W. A. M., Schnabel, R. B., Rienstra, M., van Weert, H. C. P. M., & Harskamp, R. E. (2020) · EP Europace · doi:10.1093/europace/euaa005 · Cited by 100
Aune, D., Mahamat‐Saleh, Y., Kobeissi, E., Feng, T., Heath, A. K., & Janszky, I. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-022-00914-0 · Cited by 105
Gumprecht, J. J., Domek, M., Lip, G. Y. H., & Shantsila, A. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0279-7 · Cited by 98
Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation
Chatterjee, N. A., Chae, C. U., Kim, E.-J., Moorthy, M. V., Conen, D., Sandhu, R. K., Cook, N. R., Lee, I.-M. M., & Albert, C. M. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.04.004 · Cited by 94
Monrad, M., Sajadieh, A., Christensen, J. S., Ketzel, M., Raaschou‐Nielsen, O., Tjønneland, A. M., Overvad, K., Loft, S. H., & Sørensen, M. (2016) · Environmental Health Perspectives · doi:10.1289/ehp392 · Cited by 99
Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation
Fenger‐Grøn, M., Overvad, K., Tjønneland, A. M., & Frost, L. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.558 · Cited by 96
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
Lee, S., Choi, E., Park, C. S., Han, K., Jung, J., Oh, S., & Lip, G. Y. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.051 · Cited by 92
Animal Models to Study Cardiac Arrhythmias
Blackwell, D. J., Schmeckpeper, J., & Knollmann, B. C. (2022) · Circulation Research · doi:10.1161/circresaha.122.320258 · Cited by 97
The bidirectional association between atrial fibrillation and myocardial infarction
Frederiksen, T. C., Dahm, C. C., Preis, S. R., Lin, H., Trinquart, L., Benjamin, E. J., & Kornej, J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00857-3 · Cited by 95
Dzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx013 · Cited by 91
Li, Z., Wang, Z., Yin, Z., Zhang, Y., Xue, X., Han, J., Zhu, Y., Zhang, J., Emmert, M. Y., & Wang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16342 · Cited by 93
Tan, S., Zhou, J., Veang, T., Lin, Q., & Liu, Q. (2025) · EP Europace · doi:10.1093/europace/euaf027 · Cited by 97
Stærk, L., Fosbøl, E. L., Gadsbøll, K., Sindet‐Pedersen, C., Pallisgaard, J. L., Lamberts, M., Lip, G. Y. H., Torp-Pedersen, C. T., Gislason, G., & Olesen, J. B. (2016) · Scientific Reports · doi:10.1038/srep31477 · Cited by 93
Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
Gorini, S., Kim, S. K., Infante, M., Mammi, C., Vignera, S. L., Fabbri, A., Jaffe, I. Z., & Caprio, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00584 · Cited by 90
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update
Freedman, B., Hindricks, G., Banerjee, A., Baranchuk, A. M., Ching, C. K., Du, X., Fitzsimons, D., Healey, J. S., Ikeda, T., Lobban, T., et al. (2021) · Global Heart · doi:10.5334/gh.1023 · Cited by 95
Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study
Rahman, F., Wang, N., Yin, X., Ellinor, P. T., Lubitz, S. A., LeLorier, P. A., McManus, D. D., SULLIVAN, L. M., Seshadri, S. S., Vasan, R. S., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.07.031 · Cited by 90
Seccia, T. M., Letizia, C., Muiesan, M. L., Lerco, S., Cesari, M., Bisogni, V., Petramala, L., Maiolino, G., Volpin, R., & Rossi, G. P. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002250 · Cited by 89
Khera, R., Kondamudi, N., Zhong, L., Vaduganathan, M., Parker, J., Das, S. R., Grodin, J. L., Halm, E. A., Berry, J. D., & Pandey, A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22190 · Cited by 88
Flexible Polymer Transducers for Dynamic Recognizing Physiological Signals
Xu, H., Chen, X., Tang, X., Chen, Y., Liu, J., & Shen, Q. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600008 · Cited by 89
Incidence and Predictors of Atrial Fibrillation Progression
Blum, S., Aeschbacher, S., Meyre, P. B., Zwimpfer, L., Reichlin, T., Beer, J. H., Ammann, P., Auricchio, A., Kobza, R., Erné, P., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012554 · Cited by 87
Differences in Epidemiology and Risk Factors for Atrial Fibrillation Between Women and Men
Kavousi, M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00003 · Cited by 96
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
Tam, C. S. L., Dimopoulos, M. A., García‐Sánz, R., Trotman, J., Opat, S., Roberts, A. W., Owen, R. G., Song, Y., Xu, W. L., Zhu, J., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005621 · Cited by 86
Königsbrügge, O., Posch, F., Antlanger, M., Kovařík, J., Klauser‐Braun, R., Kletzmayr, J., Schmaldienst, S., Auinger, M., Zuntner, G., Lorenz, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169400 · Cited by 83
Sharashova, E., Wilsgaard, T., Ball, J., Morseth, B., Gerdts, E., Hopstock, L. A., Mathiesen, E. B., Schirmer, H., & Løchen, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz234 · Cited by 86
Chung, S., Sofat, R., Acosta, D., Taylor, J., Lambiase, P. D., Casas, J. P., & Providencia, R. A. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100157 · Cited by 87
Ernsting, C., Stühmann, L. M., Dombrowski, S. U., Voigt‐Antons, J., Kuhlmey, A., & Gellert, P. R. (2019) · JMIR mhealth and uhealth · doi:10.2196/12179 · Cited by 91
Abdel-Qadir, H. M., Sabrie, N., Leong, D. P., Pang, A., Austin, P. C., Prica, A. A., Nanthakumar, K., Arguelles, O. C., Lee, D. S., & Thavendiranathan, P. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00693 · Cited by 82
Buiatti, A., von Olshausen, G., Barthel, P., Schneider, S., Luik, A., Kaess, B. M., Laugwitz, K., & Hoppmann, P. (2016) · EP Europace · doi:10.1093/europace/euw262 · Cited by 84
Atrial Fibrillation and Risk of Cancer: A Danish Population‐Based Cohort Study
Vinter, N., Christesen, A. M. S., Fenger‐Grøn, M., Tjønneland, A. M., & Frost, L. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009543 · Cited by 82
Vinter, N., Huang, Q., Fenger‐Grøn, M., Frost, L., Benjamin, E. J., & Trinquart, L. (2020) · BMJ · doi:10.1136/bmj.m2724 · Cited by 81
An, Y., Ogawa, H., Yamashita, Y., Ishii, M., Iguchi, M., Masunaga, N., Esato, M., Tsuji, H., Wada, H., Hasegawa, K., et al. (2018) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcy033 · Cited by 81
Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
Willems, S., Meyer, C. G., de Bono, J. P., Brandes, A., Eckardt, L., Elvan, A., Gelder, I. C. V., Goette, A., Gulizia, M. M., Haegeli, L., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz782 · Cited by 80
New-onset atrial fibrillation prediction: the HARMS2-AF risk score
Segan, L. A., Cánovas, R., Nanayakkara, S., Chieng, D., Prabhu, S., Voskoboinik, A., Sugumar, H., Ling, L., Lee, G., Morton, J. B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad375 · Cited by 90
Stroke as the Initial Manifestation of Atrial Fibrillation
Lubitz, S. A., Yin, X., McManus, D. D., Weng, L.-C. C., Aparicio, H. J., Walkey, A. J., Romero, J. R., Kase, C. S., Ellinor, P. T., Wolf, P. A., et al. (2017) · Stroke · doi:10.1161/strokeaha.116.015071 · Cited by 80
Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
Carnagarin, R., Kiuchi, M. G., Ho, J. K., Matthews, V. B., & Schlaich, M. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01058 · Cited by 81
Profiling the urinary microbiome in men with calcium-based kidney stones
Xie, J., Huang, J., Huang, X., Peng, J., Yu, Z., Yuan, Y., Xiao, K., & Guo, J. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01734-6 · Cited by 79
König, S., Ueberham, L., Schuler, E., Wiedemann, M., Reithmann, C., Seyfarth, M., Sause, A., Tebbenjohanns, J., Schade, A., Shin, D., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy528 · Cited by 78
Cheung, J. W., Cheng, E. P., X. W., Yeo, I., Christos, P. J., Kamel, H., Markowitz, S. M., Liu, C. F., Thomas, G., Ip, J. E., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz151 · Cited by 78
Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification
O’Keefe, E. L., Sturgess, J. E., O’Keefe, J. H., Gupta, S. K., & Lavie, C. J. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.08.042 · Cited by 86
Chebbout, R., Heywood, E. G., Drake, T. M., Wild, J. R. L., Lee, J., Wilson, M., & Lee, M. J. (2017) · Anaesthesia · doi:10.1111/anae.14118 · Cited by 77
Thoracoscopic Left Atrial Appendage Clipping
van Laar, C., Verberkmoes, N. J., van Es, H. W., Lewalter, T., Dunnington, G. H., STARK, S. I., Longoria, J., Hofman, F. H., Pierce, C. M., Kotecha, D., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.03.009 · Cited by 77
Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study
Shin, J., Han, K., Jung, J., Park, H., Kim, W., Huh, Y., Kim, Y., Kim, D., Kim, S. M., Choi, Y. S., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac364 · Cited by 77
Morseth, B., Geelhoed, B., Linneberg, A. R., Johansson, L., Kuulasmaa, K., Salomaa, V. V., Iacoviello, L., Costanzo, S., Söderberg, S., Niiranen, T., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001624 · Cited by 77
Benzoni, P., Campostrini, G., Landi, S., Bertini, V., Marchina, E., Iascone, M. R., Ahlberg, G., OLESEN, M. S., Crescini, E., Mora, C., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz217 · Cited by 73
Predictive value of P wave terminal force in lead V1 for atrial fibrillation: A meta‐analysis
Huang, Z., Zheng, Z., Wu, B., Tang, L., Xie, X., Dong, R., Luo, Y., Li, S., Zhu, J., & Liu, J. (2020) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12739 · Cited by 72
Sex Differences in Atrial Fibrillation Risk
Siddiqi, H. K., Moorthy, M. V., Gencer, B., Ng, C., Pester, J., Cook, N. R., Lee, I.-M. M., Buring, J. E., Manson, J. E., & Albert, C. M. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.2825 · Cited by 80
Residential exposure to traffic noise and risk of incident atrial fibrillation: A cohort study
Monrad, M., Sajadieh, A., Christensen, J. S., Ketzel, M., Raaschou‐Nielsen, O., Tjønneland, A. M., Overvad, K., Loft, S. H., & Sørensen, M. (2016) · Environment International · doi:10.1016/j.envint.2016.04.039 · Cited by 72
PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
Syeda, F., Kirchhof, P. F., & Fabritz, L. (2017) · The Journal of Physiology · doi:10.1113/jp273123 · Cited by 74
Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability
Lavan, A. H., O’Mahony, D., Buckley, M., O’Mahony, D., & Gallagher, P. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0476 · Cited by 79
Lowres, N., Giskes, K., Hespe, C. M., & Freedman, B. (2019) · Korean Circulation Journal · doi:10.4070/kcj.2019.0234 · Cited by 74
Joseph, P. G., Healey, J. S., Raina, P. S., Connolly, S. J., Ibrahim, Q. I., Gupta, R., Avezum, Á., Dans, A. L., López-Jaramillo, P. A., Yeates, K., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa241 · Cited by 73
ResNet-50 for 12-Lead Electrocardiogram Automated Diagnosis
Sakli, N., Ghabri, H., Soufiene, B. O., Almalki, F. A., Sakli, H., Ali, O., & Najjari, M. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/7617551 · Cited by 74
Cicero, A. F. G., & Colletti, A. (2016) · Phytomedicine · doi:10.1016/j.phymed.2015.10.011 · Cited by 70
Williams, B. A., Honushefsky, A. M., & Berger, P. B. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.014 · Cited by 69
Research Priorities in Atrial Fibrillation Screening
Benjamin, E. J., Go, A. S., Desvigne-Nickens, P. M., Anderson, C. D., Casadei, B., Chen, L. Y., Crijns, H. J. G. M., Freedman, B., Hills, M. T., Healey, J. S., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.047633 · Cited by 71
Epicardial adipose tissue as a mediator of cardiac arrhythmias
Patel, K. H. K., Hwang, T., Liebers, C. S., & Ng, F. S. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00565.2021 · Cited by 77
Prevalence and Incidence of Atrial Fibrillation Among Older Primary Care Patients
Khurshid, S. S., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Atlas, S. J., Singer, D. E., & Lubitz, S. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.55838 · Cited by 69
Fabritz, L., Crijns, H. J. G. M., Guasch, E., Goette, A., Häusler, K. G., Kotecha, D., Lewalter, T., Meyer, C. G., Potpara, T., Rienstra, M., et al. (2020) · EP Europace · doi:10.1093/europace/euaa279 · Cited by 70
Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study
Rahman, F., Yin, X., Larson, M. G., Ellinor, P. T., Lubitz, S. A., Vasan, R. S., McManus, D. D., Magnani, J. W., & Benjamin, E. J. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07683 · Cited by 68
Age‐Specific Vascular Risk Factor Profiles According to Stroke Subtype
Hauer, A. J., Ruigrok, Y. M., Algra, A., van Dijk, E. J., Koudstaal, P. J., Luijckx, G. J., Nederkoorn, P. J., van Oostenbrugge, R. J., de Visser, M. C. H., Wermer, M. J. H., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005090 · Cited by 68
Stroke Prevention in Nonvalvular Atrial Fibrillation
Alkhouli, M. A., Noseworthy, P. A., Rihal, C. S., & Holmes, D. R. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.013 · Cited by 70
Choi, Y., Choi, E., Han, K., Jung, J., Park, J., Lee, E., Choe, W., Lee, S., Cha, M., Lim, W., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.08.038 · Cited by 68
Blood Pressure Variability and Incidence of New-Onset Atrial Fibrillation
Lee, S., Choi, Y.-J., Choi, E., Han, K., Lee, E., Cha, M., Oh, S., & Lip, G. Y. H. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13708 · Cited by 69
Mortality in atrial fibrillation. Is it changing?
Alonso, Á., Almuwaqqat, Z., & Chamberlain, A. M. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.10.010 · Cited by 67
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism
Seccia, T. M., Caroccia, B., Adler, G. K., Maiolino, G., Cesari, M., & Rossi, G. P. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08956 · Cited by 68
Epidemiology of Atrial Fibrillation and Heart Failure
Karnik, A. A., Gopal, D. M., Ko, D., Benjamin, E. J., & Helm, R. H. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.01.001 · Cited by 66
Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications
Teppo, K., Airaksinen, J. K. E., Jaakkola, J., Halminen, O., Salmela, B., Kouki, E., Haukka, J. K., Putaala, J., Linna, M., Aro, A. L., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae198 · Cited by 66
Choi, Y.-J., Choi, E., Han, K., Park, J., Moon, I., Lee, E., Choe, W.-S., Lee, S., Cha, M., Lim, W., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2788 · Cited by 66
Increasing atrial fibrillation prevalence in acute ischemic stroke and TIA
Otite, F. O., Khandelwal, P., Chaturvedi, S., Romano, J. G., Sacco, R. L., & Malik, A. M. (2016) · Neurology · doi:10.1212/wnl.0000000000003321 · Cited by 63
Själander, S., Holmqvist, F., Smith, J. G., Platonov, P. G., Kesek, M., Svensson, P. J., Blomström‐Lundqvist, C., Tabrizi, F., Tapanainen, J. M., Poçi, D., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4179 · Cited by 64
Tralhão, A., & Póvoa, P. M. S. R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020414 · Cited by 67
Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times
Batul, S. A., & Gopinathannair, R. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0040 · Cited by 63
Elliott, A. D., Maatman, B. T., Emery, M. S., & Sanders, P. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.07.001 · Cited by 63
Yu, A., Malo, S., Svenson, L. W., Wilton, S. B., & Hill, M. D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007129 · Cited by 64
Schmidt, M., Ulrichsen, S. P., Pedersen, L. H., Bøtker, H. E., Nielsen, J. C., & Sørensen, H. T. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.071 · Cited by 62
Piccini, J. P., Allred, J. D., Bunch, T. J., Deering, T. F., Biase, L. D., Hussein, A. A., Lewis, W. R., Mittal, S., Natale, A., Osorio, J., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.04.033 · Cited by 63
Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study
Lin, H., Yin, X., Xie, Z., Lunetta, K. L., Lubitz, S. A., Larson, M. G., Ko, D., Magnani, J. W., Mendelson, M., Liu, C., et al. (2017) · Scientific Reports · doi:10.1038/srep40377 · Cited by 63
Homan, E. A., Reyes, M. V., Hickey, K. T., & Morrow, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01847 · Cited by 63
Coffee Consumption and Risk of Atrial Fibrillation in the Physicians’ Health Study
Bodar, V., Chen, J., Gaziano, J. M., Albert, C. M., & Djoussé, L. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011346 · Cited by 61
Protein Biomarkers and Risk of Atrial Fibrillation
Stærk, L., Preis, S. R., Lin, H., Lubitz, S. A., Ellinor, P. T., Levy, D. A., Benjamin, E. J., & Trinquart, L. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007607 · Cited by 61
Ding, M., Ebeling, M., Ziegler, L., Wennberg, A. M. V., & Modig, K. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100596 · Cited by 59
Steinhubl, S. R., Mehta, R. R., Ebner, G. S., Ballesteros, M. M., Waalen, J., Steinberg, G., Crocker, P. V., Felicione, E., Carter, C. T., Edmonds, S., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.02.011 · Cited by 59
Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemia
Gustine, J. N., Meid, K., Dubeau, T. E., Treon, S. P., & Castillo, J. J. (2016) · American Journal of Hematology · doi:10.1002/ajh.24366 · Cited by 59
Linschoten, M., Uijl, A., Schut, A., Jakob, C. E. M., Romão, L. R., Bell, R., McFarlane, E., Stecher, M., Zondag, A. G. M., van Iperen, E. P. A., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab656 · Cited by 63
Metadata
- Authors
- Schnabel, R. B., Yin, X., Gona, P., Larson, M. G., Beiser, A. S., McManus, D. D., Newton-Cheh, C., Lubitz, S. A., Magnani, J. W., Ellinor, P. T., Seshadri, S., Wolf, P. A., Vasan, R. S., Benjamin, E. J., & Levy, D.
- Affiliations
- Framingham Heart Study (US)
- Boston University (US)
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Schnabel, Renate B
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 386
- Issue
- 9989
- Pages
- 154-162
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4553037
- OpenAlex
- W1924098982
- Cited by
- 1,746
- References
- 32
- Citations by year
- 2026: 126 · 2025: 209 · 2024: 253 · 2023: 192 · 2022: 198 · 2021: 155 · 2020: 145 · 2019: 141 · 2018: 120 · 2017: 110 · 2016: 76 · 2015: 20
- FWCI
- 79.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- NIH/NHLBI (contract N01-HC-25195, grant 1K23HL114724)
- NIH (grants 1RC1HL101056, HL102214, and AG028321, grant 2R01HL092577, grants 1U01HL105268-01 and KL2RR031981)
- Fondation Leducq (14CVD01) and NIH grants (1R01HL092577, 1RC1HL101056, 1R01HL102214, 1R01AG028321, R01HL104156, and 1K24HL105780)
- American Heart Association Established Investigator Award (13EIA14220013)
- Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program (SCHN 1149/3-2)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- atrial fibrillation, prevalence trends, incidence trends, sex differences, risk factors, stroke, mortality, Framingham Heart Study, electrocardiogram screening, atrial fibrillation screening, atrial fibrillation prevention, cardiovascular disease prevention, long-term cohort follow-up
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Electrocardiography, Female, Humans, Male, Middle Aged, Mortality, Risk Factors, United States, Cohort Studies, Incidence, Prevalence, Age Distribution, Sex Distribution, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
